In a fit of hubris, President Trump believes he is making drug makers “come clean” by forcing them to mention list prices in their TV ads.
If only it were that simple.
The reality is that last week’s mandate may, indeed, prod recalcitrant drug makers to pay more attention to pricing and, in some cases, cast this or that company in a greedy light. But for the most part, the numbers that will soon flash across screens are likely to be confusing and, in many cases, irrelevant.
About the Author Reprints
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.